Upon taking his second oath of office as US president, Donald Trump is expected to make swift and extensive use of the ...

Investors often closely monitor such transactions by company executives to gauge insider sentiment and potential future performance of the stock. InvestingPro analysis reveals the stock's high ...

Peter Salzmann, the Chief Executive Officer of Immunovant, Inc. (NASDAQ:IMVT), a $3.49 billion market cap biotech company, ...

Stocks closed sharply higher Friday, sending the S&P 500 and Dow Jones Industrial Average to their biggest weekly gains since ...

Shares of the chipmaker are rising today alongside broader markets, leaving them up more than 8% in January and outpacing the S&P 500.

The NHL suspended forward Maxim Tsyplakov of the New York Islanders three games Friday for delivering an illegal check in a ...